fascaplysine has been researched along with Brain Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryukhovetskiy, A; Bryukhovetskiy, I; Gulaia, V; Khotimchenko, R; Lyakhova, I; Piatkova, M; Romanishin, A; Sharma, A; Sharma, HS; Shmelev, M | 1 |
| Bryukhovetskiy, A; Bryukhovetskiy, I; Kantemirov, A; Khotimchenko, R; Khotimchenko, Y; Lyakhova, I; Piatkova, M; Sharma, A; Sharma, HS; Zhidkov, M | 1 |
1 review(s) available for fascaplysine and Brain Neoplasms
| Article | Year |
|---|---|
Alkaloids of fascaplysin are promising chemotherapeutic agents for the treatment of glioblastoma: Review.
Topics: Alkaloids; Antineoplastic Agents; Brain Neoplasms; Glioblastoma; Humans; Indoles | 2020 |
1 other study(ies) available for fascaplysine and Brain Neoplasms
| Article | Year |
|---|---|
3-Bromofascaplysin is a prospective chemical compound for developing new chemotherapy agents in glioblastoma treatment.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Indoles; Rats | 2020 |